Genmab will publish its Interim Report for the First Half 2026 on August 6, 2026, after 5:00 pm CEST.
A conference call to discuss Genmab’s Second Quarter 2026 Financial Results will be held the same day at 6:00 pm CEST / 12:00 pm EDT.
To join the call please use the registration link. Registered participants will receive an email with a link to access dial-in information as well as a unique personal PIN.
Genmab held a conference call to discuss its Q1 2026 financial results on May 7, 2026.
The Annual General Meeting 2026 will take place on Thursday, March 19, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, 1560 Copenhagen, Denmark.
Genmab will hold a conference call to discuss its 2025 financial results at 6:00 pm CET, 5:00 pm GMT or 12:00 pm EST on February 17, 2026
On August 7, Genmab announced its financial results for the first half of 2025.
On May 8, Genmab announced its financial results for the first quarter of 2025.
The Annual General Meeting 2025 took place on Wednesday, March 12, 2025, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, 1560 Copenhagen, Denmark.
On February 12, Genmab announced its full-year financial results for 2024.
On November 6, Genmab announced its financial results for the first nine months of 2024.
On August 8, Genmab announced its financial results for the first six months of 2024.